Biotech News
Related news
ALVOAlvotech2026-10-05 08:00 EST
Matvæla- og lyfjastofnun Bandaríkjanna (FDA) veitir viðbótarleyfi fyrir framleiðslu á hliðstæðunni við Humira í báðum framleiðslueiningum lyfjaverksmiðju Alvotech í Reykjavík
ALVOAlvotech2026-08-31 08:30 EST
Matvæla- og lyfjastofnun Bandaríkjanna (FDA) tekur til afgreiðslu umsókn Alvotech um markaðsleyfi fyrir fyrirhugaða hliðstæðu við Entyvio í sprautu eða lyfjapenna
ANIPANI Pharmaceuticals2026-09-23 10:55 EST
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension
AMRXAmneal Pharmaceuticals2026-09-18 20:01 EST
Amneal Announces FDA Approval and Launch of Lanreotide Injection
AMRXAmneal Pharmaceuticals2026-07-17 12:00 EST
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
ADMAADMA Biologics2026-05-04 11:00 EST
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older
ANIPANI Pharmaceuticals2026-04-20 10:50 EST
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
RHHBYRoche Holdings AG2026-10-16 05:00 EST
FDA approves Roche’s Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
RHHBYRoche Holdings AG2026-10-09 05:00 EST
FDA approves Roche’s Tecentriq in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage III colon cancer
PHARPharming Group2026-09-25 14:30 EST
Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS
Alvotech
Global Biosimilar Developer and Manufacturer Alvotech is a biotechnology company focused exclusively on developing and manufacturing biosimilar medicines. It operates an integrated model covering cell-line development, process development, clinical studies, regulatory submissions, commercial-scale manufacturing, and supply to regional...
Recent company news
ALVOAlvotech2026-10-20 08:30 EST
Lyfjastofnun Bandaríkjanna samþykkir nýja framleiðsluaðferð Alvotech sem rúmlega tvöfaldar afköst við framleiðslu á Simlandi
ALVOAlvotech2026-10-14 08:30 EST
Alvotech og Advanz Pharma fyrst til að sækja um markaðsleyfi fyrir hliðstæðu við augnlyfið Eylea í háum styrk
ALVOAlvotech2026-10-06 20:37 EST
Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply
ALVOAlvotech2026-10-06 20:30 EST
Alvotech semur við LOTTE Biologics í Syracuse í Bandaríkjunum um framleiðslu á líftæknilyfjahliðstæðum og eykur þannig framleiðslugetu sína
ALVOAlvotech2026-10-05 08:00 EST
Matvæla- og lyfjastofnun Bandaríkjanna (FDA) veitir viðbótarleyfi fyrir framleiðslu á hliðstæðunni við Humira í báðum framleiðslueiningum lyfjaverksmiðju Alvotech í Reykjavík
Stock data
- Close
- 5.13 USD
- Market cap
- 936.14M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States